Aurora Spine Corporation
Aurora Spine Corporation (ASAPF) Stock Competitors & Peer Comparison
See (ASAPF) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| ASAPF | $0.25 | +0.00% | 19.5M | -25.00 | -$0.01 | N/A |
| SMMNY | $28.18 | +0.51% | 126.5B | 25.86 | $1.09 | +1.05% |
| SEMHF | $54.72 | -3.83% | 61.4B | 25.33 | $2.16 | +1.81% |
| RYLPF | $25.69 | -1.24% | 24.4B | 85.63 | $0.30 | +3.70% |
| SONVY | $58.80 | -0.08% | 17.5B | 25.79 | $2.28 | +1.07% |
| SONVF | $288.61 | -3.73% | 17.2B | 25.34 | $11.39 | +1.81% |
| CHEOY | $102.47 | -0.67% | 13.4B | 55.69 | $1.84 | +1.36% |
| SNNUF | $14.94 | +1.29% | 13.1B | 31.79 | $0.47 | +2.51% |
| CHEOF | $195.55 | +1.30% | 12.8B | 52.71 | $3.71 | +1.42% |
| WILLF | $43.77 | -0.01% | 9B | 21.14 | $2.07 | N/A |
Stock Comparison
ASAPF vs SMMNY Comparison July 2025
ASAPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASAPF stands at 19.5M. In comparison, SMMNY has a market cap of 126.5B. Regarding current trading prices, ASAPF is priced at $0.25, while SMMNY trades at $28.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASAPF currently has a P/E ratio of -25.00, whereas SMMNY's P/E ratio is 25.86. In terms of profitability, ASAPF's ROE is -0.23%, compared to SMMNY's ROE of +0.11%. Regarding short-term risk, ASAPF is more volatile compared to SMMNY. This indicates potentially higher risk in terms of short-term price fluctuations for ASAPF.Check SMMNY's competition here
ASAPF vs SEMHF Comparison July 2025
ASAPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASAPF stands at 19.5M. In comparison, SEMHF has a market cap of 61.4B. Regarding current trading prices, ASAPF is priced at $0.25, while SEMHF trades at $54.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASAPF currently has a P/E ratio of -25.00, whereas SEMHF's P/E ratio is 25.33. In terms of profitability, ASAPF's ROE is -0.23%, compared to SEMHF's ROE of +0.11%. Regarding short-term risk, ASAPF is less volatile compared to SEMHF. This indicates potentially lower risk in terms of short-term price fluctuations for ASAPF.Check SEMHF's competition here
ASAPF vs RYLPF Comparison July 2025
ASAPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASAPF stands at 19.5M. In comparison, RYLPF has a market cap of 24.4B. Regarding current trading prices, ASAPF is priced at $0.25, while RYLPF trades at $25.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASAPF currently has a P/E ratio of -25.00, whereas RYLPF's P/E ratio is 85.63. In terms of profitability, ASAPF's ROE is -0.23%, compared to RYLPF's ROE of +0.03%. Regarding short-term risk, ASAPF is more volatile compared to RYLPF. This indicates potentially higher risk in terms of short-term price fluctuations for ASAPF.Check RYLPF's competition here
ASAPF vs SONVY Comparison July 2025
ASAPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASAPF stands at 19.5M. In comparison, SONVY has a market cap of 17.5B. Regarding current trading prices, ASAPF is priced at $0.25, while SONVY trades at $58.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASAPF currently has a P/E ratio of -25.00, whereas SONVY's P/E ratio is 25.79. In terms of profitability, ASAPF's ROE is -0.23%, compared to SONVY's ROE of +0.21%. Regarding short-term risk, ASAPF is more volatile compared to SONVY. This indicates potentially higher risk in terms of short-term price fluctuations for ASAPF.Check SONVY's competition here
ASAPF vs SONVF Comparison July 2025
ASAPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASAPF stands at 19.5M. In comparison, SONVF has a market cap of 17.2B. Regarding current trading prices, ASAPF is priced at $0.25, while SONVF trades at $288.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASAPF currently has a P/E ratio of -25.00, whereas SONVF's P/E ratio is 25.34. In terms of profitability, ASAPF's ROE is -0.23%, compared to SONVF's ROE of +0.22%. Regarding short-term risk, ASAPF is more volatile compared to SONVF. This indicates potentially higher risk in terms of short-term price fluctuations for ASAPF.Check SONVF's competition here
ASAPF vs CHEOY Comparison July 2025
ASAPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASAPF stands at 19.5M. In comparison, CHEOY has a market cap of 13.4B. Regarding current trading prices, ASAPF is priced at $0.25, while CHEOY trades at $102.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASAPF currently has a P/E ratio of -25.00, whereas CHEOY's P/E ratio is 55.69. In terms of profitability, ASAPF's ROE is -0.23%, compared to CHEOY's ROE of +0.20%. Regarding short-term risk, ASAPF is less volatile compared to CHEOY. This indicates potentially lower risk in terms of short-term price fluctuations for ASAPF.Check CHEOY's competition here
ASAPF vs SNNUF Comparison July 2025
ASAPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASAPF stands at 19.5M. In comparison, SNNUF has a market cap of 13.1B. Regarding current trading prices, ASAPF is priced at $0.25, while SNNUF trades at $14.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASAPF currently has a P/E ratio of -25.00, whereas SNNUF's P/E ratio is 31.79. In terms of profitability, ASAPF's ROE is -0.23%, compared to SNNUF's ROE of +0.08%. Regarding short-term risk, ASAPF is more volatile compared to SNNUF. This indicates potentially higher risk in terms of short-term price fluctuations for ASAPF.Check SNNUF's competition here
ASAPF vs CHEOF Comparison July 2025
ASAPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASAPF stands at 19.5M. In comparison, CHEOF has a market cap of 12.8B. Regarding current trading prices, ASAPF is priced at $0.25, while CHEOF trades at $195.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASAPF currently has a P/E ratio of -25.00, whereas CHEOF's P/E ratio is 52.71. In terms of profitability, ASAPF's ROE is -0.23%, compared to CHEOF's ROE of +0.20%. Regarding short-term risk, ASAPF is more volatile compared to CHEOF. This indicates potentially higher risk in terms of short-term price fluctuations for ASAPF.Check CHEOF's competition here
ASAPF vs WILLF Comparison July 2025
ASAPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASAPF stands at 19.5M. In comparison, WILLF has a market cap of 9B. Regarding current trading prices, ASAPF is priced at $0.25, while WILLF trades at $43.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASAPF currently has a P/E ratio of -25.00, whereas WILLF's P/E ratio is 21.14. In terms of profitability, ASAPF's ROE is -0.23%, compared to WILLF's ROE of +0.25%. Regarding short-term risk, ASAPF is more volatile compared to WILLF. This indicates potentially higher risk in terms of short-term price fluctuations for ASAPF.Check WILLF's competition here
ASAPF vs WILYY Comparison July 2025
ASAPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASAPF stands at 19.5M. In comparison, WILYY has a market cap of 8.6B. Regarding current trading prices, ASAPF is priced at $0.25, while WILYY trades at $20.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASAPF currently has a P/E ratio of -25.00, whereas WILYY's P/E ratio is 19.41. In terms of profitability, ASAPF's ROE is -0.23%, compared to WILYY's ROE of +0.25%. Regarding short-term risk, ASAPF is less volatile compared to WILYY. This indicates potentially lower risk in terms of short-term price fluctuations for ASAPF.Check WILYY's competition here
ASAPF vs GNGBY Comparison July 2025
ASAPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASAPF stands at 19.5M. In comparison, GNGBY has a market cap of 5.8B. Regarding current trading prices, ASAPF is priced at $0.25, while GNGBY trades at $21.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASAPF currently has a P/E ratio of -25.00, whereas GNGBY's P/E ratio is 37.52. In terms of profitability, ASAPF's ROE is -0.23%, compared to GNGBY's ROE of +0.05%. Regarding short-term risk, ASAPF is more volatile compared to GNGBY. This indicates potentially higher risk in terms of short-term price fluctuations for ASAPF.Check GNGBY's competition here
ASAPF vs GNGBF Comparison July 2025
ASAPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASAPF stands at 19.5M. In comparison, GNGBF has a market cap of 5.7B. Regarding current trading prices, ASAPF is priced at $0.25, while GNGBF trades at $21.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASAPF currently has a P/E ratio of -25.00, whereas GNGBF's P/E ratio is 36.84. In terms of profitability, ASAPF's ROE is -0.23%, compared to GNGBF's ROE of +0.05%. Regarding short-term risk, ASAPF is more volatile compared to GNGBF. This indicates potentially higher risk in terms of short-term price fluctuations for ASAPF.Check GNGBF's competition here
ASAPF vs AMBBY Comparison July 2025
ASAPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASAPF stands at 19.5M. In comparison, AMBBY has a market cap of 4.2B. Regarding current trading prices, ASAPF is priced at $0.25, while AMBBY trades at $15.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASAPF currently has a P/E ratio of -25.00, whereas AMBBY's P/E ratio is 70.05. In terms of profitability, ASAPF's ROE is -0.23%, compared to AMBBY's ROE of +0.06%. Regarding short-term risk, ASAPF is more volatile compared to AMBBY. This indicates potentially higher risk in terms of short-term price fluctuations for ASAPF.Check AMBBY's competition here
ASAPF vs NHNKY Comparison July 2025
ASAPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASAPF stands at 19.5M. In comparison, NHNKY has a market cap of 4.1B. Regarding current trading prices, ASAPF is priced at $0.25, while NHNKY trades at $12.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASAPF currently has a P/E ratio of -25.00, whereas NHNKY's P/E ratio is 22.00. In terms of profitability, ASAPF's ROE is -0.23%, compared to NHNKY's ROE of +0.08%. Regarding short-term risk, ASAPF is less volatile compared to NHNKY. This indicates potentially lower risk in terms of short-term price fluctuations for ASAPF.Check NHNKY's competition here
ASAPF vs AMBFF Comparison July 2025
ASAPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASAPF stands at 19.5M. In comparison, AMBFF has a market cap of 4B. Regarding current trading prices, ASAPF is priced at $0.25, while AMBFF trades at $15.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASAPF currently has a P/E ratio of -25.00, whereas AMBFF's P/E ratio is 69.09. In terms of profitability, ASAPF's ROE is -0.23%, compared to AMBFF's ROE of +0.06%. Regarding short-term risk, ASAPF is less volatile compared to AMBFF. This indicates potentially lower risk in terms of short-term price fluctuations for ASAPF.Check AMBFF's competition here
ASAPF vs NHNKF Comparison July 2025
ASAPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASAPF stands at 19.5M. In comparison, NHNKF has a market cap of 2.5B. Regarding current trading prices, ASAPF is priced at $0.25, while NHNKF trades at $15.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASAPF currently has a P/E ratio of -25.00, whereas NHNKF's P/E ratio is 41.86. In terms of profitability, ASAPF's ROE is -0.23%, compared to NHNKF's ROE of +0.08%. Regarding short-term risk, ASAPF is less volatile compared to NHNKF. This indicates potentially lower risk in terms of short-term price fluctuations for ASAPF.Check NHNKF's competition here
ASAPF vs GNNDY Comparison July 2025
ASAPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASAPF stands at 19.5M. In comparison, GNNDY has a market cap of 2.3B. Regarding current trading prices, ASAPF is priced at $0.25, while GNNDY trades at $48.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASAPF currently has a P/E ratio of -25.00, whereas GNNDY's P/E ratio is 18.76. In terms of profitability, ASAPF's ROE is -0.23%, compared to GNNDY's ROE of +0.08%. Regarding short-term risk, ASAPF is more volatile compared to GNNDY. This indicates potentially higher risk in terms of short-term price fluctuations for ASAPF.Check GNNDY's competition here
ASAPF vs GGNDF Comparison July 2025
ASAPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASAPF stands at 19.5M. In comparison, GGNDF has a market cap of 2.1B. Regarding current trading prices, ASAPF is priced at $0.25, while GGNDF trades at $14.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASAPF currently has a P/E ratio of -25.00, whereas GGNDF's P/E ratio is 16.53. In terms of profitability, ASAPF's ROE is -0.23%, compared to GGNDF's ROE of +0.08%. Regarding short-term risk, ASAPF is less volatile compared to GGNDF. This indicates potentially lower risk in terms of short-term price fluctuations for ASAPF.Check GGNDF's competition here
ASAPF vs MCRPF Comparison July 2025
ASAPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASAPF stands at 19.5M. In comparison, MCRPF has a market cap of 2.1B. Regarding current trading prices, ASAPF is priced at $0.25, while MCRPF trades at $1.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASAPF currently has a P/E ratio of -25.00, whereas MCRPF's P/E ratio is -9.33. In terms of profitability, ASAPF's ROE is -0.23%, compared to MCRPF's ROE of -0.33%. Regarding short-term risk, ASAPF is less volatile compared to MCRPF. This indicates potentially lower risk in terms of short-term price fluctuations for ASAPF.Check MCRPF's competition here
ASAPF vs STSEY Comparison July 2025
ASAPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASAPF stands at 19.5M. In comparison, STSEY has a market cap of 2B. Regarding current trading prices, ASAPF is priced at $0.25, while STSEY trades at $6.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASAPF currently has a P/E ratio of -25.00, whereas STSEY's P/E ratio is 39.41. In terms of profitability, ASAPF's ROE is -0.23%, compared to STSEY's ROE of +0.07%. Regarding short-term risk, ASAPF is more volatile compared to STSEY. This indicates potentially higher risk in terms of short-term price fluctuations for ASAPF.Check STSEY's competition here
ASAPF vs VTRLY Comparison July 2025
ASAPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASAPF stands at 19.5M. In comparison, VTRLY has a market cap of 2B. Regarding current trading prices, ASAPF is priced at $0.25, while VTRLY trades at $14.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASAPF currently has a P/E ratio of -25.00, whereas VTRLY's P/E ratio is 42.80. In terms of profitability, ASAPF's ROE is -0.23%, compared to VTRLY's ROE of +0.04%. Regarding short-term risk, ASAPF is more volatile compared to VTRLY. This indicates potentially higher risk in terms of short-term price fluctuations for ASAPF.Check VTRLY's competition here
ASAPF vs OSSFF Comparison July 2025
ASAPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASAPF stands at 19.5M. In comparison, OSSFF has a market cap of 1.8B. Regarding current trading prices, ASAPF is priced at $0.25, while OSSFF trades at $4.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASAPF currently has a P/E ratio of -25.00, whereas OSSFF's P/E ratio is 24.41. In terms of profitability, ASAPF's ROE is -0.23%, compared to OSSFF's ROE of +0.09%. Regarding short-term risk, ASAPF is less volatile compared to OSSFF. This indicates potentially lower risk in terms of short-term price fluctuations for ASAPF.Check OSSFF's competition here
ASAPF vs DWRKF Comparison July 2025
ASAPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASAPF stands at 19.5M. In comparison, DWRKF has a market cap of 1.8B. Regarding current trading prices, ASAPF is priced at $0.25, while DWRKF trades at $543.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASAPF currently has a P/E ratio of -25.00, whereas DWRKF's P/E ratio is 75.94. In terms of profitability, ASAPF's ROE is -0.23%, compared to DWRKF's ROE of N/A. Regarding short-term risk, ASAPF is more volatile compared to DWRKF. This indicates potentially higher risk in terms of short-term price fluctuations for ASAPF.Check DWRKF's competition here
ASAPF vs OSSUY Comparison July 2025
ASAPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASAPF stands at 19.5M. In comparison, OSSUY has a market cap of 1.7B. Regarding current trading prices, ASAPF is priced at $0.25, while OSSUY trades at $4.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASAPF currently has a P/E ratio of -25.00, whereas OSSUY's P/E ratio is 23.53. In terms of profitability, ASAPF's ROE is -0.23%, compared to OSSUY's ROE of +0.09%. Regarding short-term risk, ASAPF is more volatile compared to OSSUY. This indicates potentially higher risk in terms of short-term price fluctuations for ASAPF.Check OSSUY's competition here
ASAPF vs MEDGF Comparison July 2025
ASAPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASAPF stands at 19.5M. In comparison, MEDGF has a market cap of 1.7B. Regarding current trading prices, ASAPF is priced at $0.25, while MEDGF trades at $83.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASAPF currently has a P/E ratio of -25.00, whereas MEDGF's P/E ratio is 33.30. In terms of profitability, ASAPF's ROE is -0.23%, compared to MEDGF's ROE of +0.16%. Regarding short-term risk, ASAPF is more volatile compared to MEDGF. This indicates potentially higher risk in terms of short-term price fluctuations for ASAPF.Check MEDGF's competition here
ASAPF vs DRWKF Comparison July 2025
ASAPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASAPF stands at 19.5M. In comparison, DRWKF has a market cap of 1.4B. Regarding current trading prices, ASAPF is priced at $0.25, while DRWKF trades at $67.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASAPF currently has a P/E ratio of -25.00, whereas DRWKF's P/E ratio is 9.40. In terms of profitability, ASAPF's ROE is -0.23%, compared to DRWKF's ROE of +0.09%. Regarding short-term risk, ASAPF is more volatile compared to DRWKF. This indicates potentially higher risk in terms of short-term price fluctuations for ASAPF.Check DRWKF's competition here
ASAPF vs DGWPF Comparison July 2025
ASAPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASAPF stands at 19.5M. In comparison, DGWPF has a market cap of 1.2B. Regarding current trading prices, ASAPF is priced at $0.25, while DGWPF trades at $57.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASAPF currently has a P/E ratio of -25.00, whereas DGWPF's P/E ratio is 7.94. In terms of profitability, ASAPF's ROE is -0.23%, compared to DGWPF's ROE of +0.09%. Regarding short-term risk, ASAPF is less volatile compared to DGWPF. This indicates potentially lower risk in terms of short-term price fluctuations for ASAPF.Check DGWPF's competition here
ASAPF vs ELEAF Comparison July 2025
ASAPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASAPF stands at 19.5M. In comparison, ELEAF has a market cap of 1.1B. Regarding current trading prices, ASAPF is priced at $0.25, while ELEAF trades at $13.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASAPF currently has a P/E ratio of -25.00, whereas ELEAF's P/E ratio is 15.51. In terms of profitability, ASAPF's ROE is -0.23%, compared to ELEAF's ROE of +0.15%. Regarding short-term risk, ASAPF is more volatile compared to ELEAF. This indicates potentially higher risk in terms of short-term price fluctuations for ASAPF.Check ELEAF's competition here
ASAPF vs LFTSF Comparison July 2025
ASAPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASAPF stands at 19.5M. In comparison, LFTSF has a market cap of 1B. Regarding current trading prices, ASAPF is priced at $0.25, while LFTSF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASAPF currently has a P/E ratio of -25.00, whereas LFTSF's P/E ratio is 23.35. In terms of profitability, ASAPF's ROE is -0.23%, compared to LFTSF's ROE of +0.07%. Regarding short-term risk, ASAPF is more volatile compared to LFTSF. This indicates potentially higher risk in terms of short-term price fluctuations for ASAPF.Check LFTSF's competition here
ASAPF vs MDRSF Comparison July 2025
ASAPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASAPF stands at 19.5M. In comparison, MDRSF has a market cap of 828.1M. Regarding current trading prices, ASAPF is priced at $0.25, while MDRSF trades at $66.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASAPF currently has a P/E ratio of -25.00, whereas MDRSF's P/E ratio is 196.12. In terms of profitability, ASAPF's ROE is -0.23%, compared to MDRSF's ROE of +0.01%. Regarding short-term risk, ASAPF is less volatile compared to MDRSF. This indicates potentially lower risk in terms of short-term price fluctuations for ASAPF.Check MDRSF's competition here
ASAPF vs XVIPF Comparison July 2025
ASAPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASAPF stands at 19.5M. In comparison, XVIPF has a market cap of 693M. Regarding current trading prices, ASAPF is priced at $0.25, while XVIPF trades at $22.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASAPF currently has a P/E ratio of -25.00, whereas XVIPF's P/E ratio is 59.46. In terms of profitability, ASAPF's ROE is -0.23%, compared to XVIPF's ROE of +0.07%. Regarding short-term risk, ASAPF is less volatile compared to XVIPF. This indicates potentially lower risk in terms of short-term price fluctuations for ASAPF.Check XVIPF's competition here
ASAPF vs CALZF Comparison July 2025
ASAPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASAPF stands at 19.5M. In comparison, CALZF has a market cap of 584.3M. Regarding current trading prices, ASAPF is priced at $0.25, while CALZF trades at $0.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASAPF currently has a P/E ratio of -25.00, whereas CALZF's P/E ratio is 84.58. In terms of profitability, ASAPF's ROE is -0.23%, compared to CALZF's ROE of +0.07%. Regarding short-term risk, ASAPF is more volatile compared to CALZF. This indicates potentially higher risk in terms of short-term price fluctuations for ASAPF.Check CALZF's competition here
ASAPF vs AVMR Comparison July 2025
ASAPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASAPF stands at 19.5M. In comparison, AVMR has a market cap of 494.2M. Regarding current trading prices, ASAPF is priced at $0.25, while AVMR trades at $9.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASAPF currently has a P/E ratio of -25.00, whereas AVMR's P/E ratio is -18.34. In terms of profitability, ASAPF's ROE is -0.23%, compared to AVMR's ROE of -1.38%. Regarding short-term risk, ASAPF is more volatile compared to AVMR. This indicates potentially higher risk in terms of short-term price fluctuations for ASAPF.Check AVMR's competition here
ASAPF vs CLVSF Comparison July 2025
ASAPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASAPF stands at 19.5M. In comparison, CLVSF has a market cap of 459.8M. Regarding current trading prices, ASAPF is priced at $0.25, while CLVSF trades at $19.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASAPF currently has a P/E ratio of -25.00, whereas CLVSF's P/E ratio is 31.61. In terms of profitability, ASAPF's ROE is -0.23%, compared to CLVSF's ROE of +0.19%. Regarding short-term risk, ASAPF is more volatile compared to CLVSF. This indicates potentially higher risk in terms of short-term price fluctuations for ASAPF.Check CLVSF's competition here
ASAPF vs IOBCF Comparison July 2025
ASAPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASAPF stands at 19.5M. In comparison, IOBCF has a market cap of 407.5M. Regarding current trading prices, ASAPF is priced at $0.25, while IOBCF trades at $13.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASAPF currently has a P/E ratio of -25.00, whereas IOBCF's P/E ratio is 37.59. In terms of profitability, ASAPF's ROE is -0.23%, compared to IOBCF's ROE of +0.09%. Regarding short-term risk, ASAPF is more volatile compared to IOBCF. This indicates potentially higher risk in terms of short-term price fluctuations for ASAPF.Check IOBCF's competition here
ASAPF vs CSSPF Comparison July 2025
ASAPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASAPF stands at 19.5M. In comparison, CSSPF has a market cap of 384M. Regarding current trading prices, ASAPF is priced at $0.25, while CSSPF trades at $0.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASAPF currently has a P/E ratio of -25.00, whereas CSSPF's P/E ratio is 92.00. In terms of profitability, ASAPF's ROE is -0.23%, compared to CSSPF's ROE of +0.16%. Regarding short-term risk, ASAPF is less volatile compared to CSSPF. This indicates potentially lower risk in terms of short-term price fluctuations for ASAPF.Check CSSPF's competition here
ASAPF vs HYBT Comparison July 2025
ASAPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASAPF stands at 19.5M. In comparison, HYBT has a market cap of 361.4M. Regarding current trading prices, ASAPF is priced at $0.25, while HYBT trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASAPF currently has a P/E ratio of -25.00, whereas HYBT's P/E ratio is N/A. In terms of profitability, ASAPF's ROE is -0.23%, compared to HYBT's ROE of -0.00%. Regarding short-term risk, ASAPF is more volatile compared to HYBT. This indicates potentially higher risk in terms of short-term price fluctuations for ASAPF.Check HYBT's competition here
ASAPF vs EAPIF Comparison July 2025
ASAPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASAPF stands at 19.5M. In comparison, EAPIF has a market cap of 347.6M. Regarding current trading prices, ASAPF is priced at $0.25, while EAPIF trades at $3.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASAPF currently has a P/E ratio of -25.00, whereas EAPIF's P/E ratio is -2.25. In terms of profitability, ASAPF's ROE is -0.23%, compared to EAPIF's ROE of -0.31%. Regarding short-term risk, ASAPF is more volatile compared to EAPIF. This indicates potentially higher risk in terms of short-term price fluctuations for ASAPF.Check EAPIF's competition here
ASAPF vs CYBQY Comparison July 2025
ASAPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASAPF stands at 19.5M. In comparison, CYBQY has a market cap of 266.8M. Regarding current trading prices, ASAPF is priced at $0.25, while CYBQY trades at $1.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASAPF currently has a P/E ratio of -25.00, whereas CYBQY's P/E ratio is -52.00. In terms of profitability, ASAPF's ROE is -0.23%, compared to CYBQY's ROE of -0.01%. Regarding short-term risk, ASAPF is less volatile compared to CYBQY. This indicates potentially lower risk in terms of short-term price fluctuations for ASAPF.Check CYBQY's competition here
ASAPF vs BRSYF Comparison July 2025
ASAPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASAPF stands at 19.5M. In comparison, BRSYF has a market cap of 256.2M. Regarding current trading prices, ASAPF is priced at $0.25, while BRSYF trades at $6.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASAPF currently has a P/E ratio of -25.00, whereas BRSYF's P/E ratio is 61.64. In terms of profitability, ASAPF's ROE is -0.23%, compared to BRSYF's ROE of +0.07%. Regarding short-term risk, ASAPF is less volatile compared to BRSYF. This indicates potentially lower risk in terms of short-term price fluctuations for ASAPF.Check BRSYF's competition here
ASAPF vs CLLKF Comparison July 2025
ASAPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASAPF stands at 19.5M. In comparison, CLLKF has a market cap of 245.2M. Regarding current trading prices, ASAPF is priced at $0.25, while CLLKF trades at $3.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASAPF currently has a P/E ratio of -25.00, whereas CLLKF's P/E ratio is -7.89. In terms of profitability, ASAPF's ROE is -0.23%, compared to CLLKF's ROE of -0.12%. Regarding short-term risk, ASAPF is less volatile compared to CLLKF. This indicates potentially lower risk in terms of short-term price fluctuations for ASAPF.Check CLLKF's competition here
ASAPF vs HTLZF Comparison July 2025
ASAPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASAPF stands at 19.5M. In comparison, HTLZF has a market cap of 245.1M. Regarding current trading prices, ASAPF is priced at $0.25, while HTLZF trades at $1.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASAPF currently has a P/E ratio of -25.00, whereas HTLZF's P/E ratio is -159.01. In terms of profitability, ASAPF's ROE is -0.23%, compared to HTLZF's ROE of -0.03%. Regarding short-term risk, ASAPF is more volatile compared to HTLZF. This indicates potentially higher risk in terms of short-term price fluctuations for ASAPF.Check HTLZF's competition here
ASAPF vs BCCOY Comparison July 2025
ASAPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASAPF stands at 19.5M. In comparison, BCCOY has a market cap of 221M. Regarding current trading prices, ASAPF is priced at $0.25, while BCCOY trades at $0.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASAPF currently has a P/E ratio of -25.00, whereas BCCOY's P/E ratio is -7.27. In terms of profitability, ASAPF's ROE is -0.23%, compared to BCCOY's ROE of -0.12%. Regarding short-term risk, ASAPF is less volatile compared to BCCOY. This indicates potentially lower risk in terms of short-term price fluctuations for ASAPF.Check BCCOY's competition here
ASAPF vs IMPZY Comparison July 2025
ASAPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASAPF stands at 19.5M. In comparison, IMPZY has a market cap of 199.9M. Regarding current trading prices, ASAPF is priced at $0.25, while IMPZY trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASAPF currently has a P/E ratio of -25.00, whereas IMPZY's P/E ratio is -1.60. In terms of profitability, ASAPF's ROE is -0.23%, compared to IMPZY's ROE of -2.86%. Regarding short-term risk, ASAPF is more volatile compared to IMPZY. This indicates potentially higher risk in terms of short-term price fluctuations for ASAPF.Check IMPZY's competition here
ASAPF vs PXMBF Comparison July 2025
ASAPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASAPF stands at 19.5M. In comparison, PXMBF has a market cap of 187.5M. Regarding current trading prices, ASAPF is priced at $0.25, while PXMBF trades at $3.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASAPF currently has a P/E ratio of -25.00, whereas PXMBF's P/E ratio is 29.17. In terms of profitability, ASAPF's ROE is -0.23%, compared to PXMBF's ROE of +0.12%. Regarding short-term risk, ASAPF is more volatile compared to PXMBF. This indicates potentially higher risk in terms of short-term price fluctuations for ASAPF.Check PXMBF's competition here
ASAPF vs DTXMF Comparison July 2025
ASAPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASAPF stands at 19.5M. In comparison, DTXMF has a market cap of 180.6M. Regarding current trading prices, ASAPF is priced at $0.25, while DTXMF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASAPF currently has a P/E ratio of -25.00, whereas DTXMF's P/E ratio is -9.52. In terms of profitability, ASAPF's ROE is -0.23%, compared to DTXMF's ROE of -0.41%. Regarding short-term risk, ASAPF is less volatile compared to DTXMF. This indicates potentially lower risk in terms of short-term price fluctuations for ASAPF.Check DTXMF's competition here
ASAPF vs AVHHL Comparison July 2025
ASAPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASAPF stands at 19.5M. In comparison, AVHHL has a market cap of 167.7M. Regarding current trading prices, ASAPF is priced at $0.25, while AVHHL trades at $1.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASAPF currently has a P/E ratio of -25.00, whereas AVHHL's P/E ratio is -3.07. In terms of profitability, ASAPF's ROE is -0.23%, compared to AVHHL's ROE of -3.38%. Regarding short-term risk, ASAPF is less volatile compared to AVHHL. This indicates potentially lower risk in terms of short-term price fluctuations for ASAPF.Check AVHHL's competition here
ASAPF vs CYBQF Comparison July 2025
ASAPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASAPF stands at 19.5M. In comparison, CYBQF has a market cap of 160.1M. Regarding current trading prices, ASAPF is priced at $0.25, while CYBQF trades at $1.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASAPF currently has a P/E ratio of -25.00, whereas CYBQF's P/E ratio is -60.00. In terms of profitability, ASAPF's ROE is -0.23%, compared to CYBQF's ROE of -0.01%. Regarding short-term risk, ASAPF is more volatile compared to CYBQF. This indicates potentially higher risk in terms of short-term price fluctuations for ASAPF.Check CYBQF's competition here
ASAPF vs EKDHF Comparison July 2025
ASAPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASAPF stands at 19.5M. In comparison, EKDHF has a market cap of 157.2M. Regarding current trading prices, ASAPF is priced at $0.25, while EKDHF trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASAPF currently has a P/E ratio of -25.00, whereas EKDHF's P/E ratio is 17.50. In terms of profitability, ASAPF's ROE is -0.23%, compared to EKDHF's ROE of +0.09%. Regarding short-term risk, ASAPF is less volatile compared to EKDHF. This indicates potentially lower risk in terms of short-term price fluctuations for ASAPF.Check EKDHF's competition here
ASAPF vs DMTRF Comparison July 2025
ASAPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASAPF stands at 19.5M. In comparison, DMTRF has a market cap of 154.9M. Regarding current trading prices, ASAPF is priced at $0.25, while DMTRF trades at $0.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASAPF currently has a P/E ratio of -25.00, whereas DMTRF's P/E ratio is -9.86. In terms of profitability, ASAPF's ROE is -0.23%, compared to DMTRF's ROE of -0.24%. Regarding short-term risk, ASAPF is less volatile compared to DMTRF. This indicates potentially lower risk in terms of short-term price fluctuations for ASAPF.Check DMTRF's competition here
ASAPF vs AMEUF Comparison July 2025
ASAPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASAPF stands at 19.5M. In comparison, AMEUF has a market cap of 120.5M. Regarding current trading prices, ASAPF is priced at $0.25, while AMEUF trades at $5.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASAPF currently has a P/E ratio of -25.00, whereas AMEUF's P/E ratio is -1.75. In terms of profitability, ASAPF's ROE is -0.23%, compared to AMEUF's ROE of -5.13%. Regarding short-term risk, ASAPF is less volatile compared to AMEUF. This indicates potentially lower risk in terms of short-term price fluctuations for ASAPF.Check AMEUF's competition here
ASAPF vs SNZZF Comparison July 2025
ASAPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASAPF stands at 19.5M. In comparison, SNZZF has a market cap of 114.8M. Regarding current trading prices, ASAPF is priced at $0.25, while SNZZF trades at $0.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASAPF currently has a P/E ratio of -25.00, whereas SNZZF's P/E ratio is -7.30. In terms of profitability, ASAPF's ROE is -0.23%, compared to SNZZF's ROE of -0.40%. Regarding short-term risk, ASAPF is more volatile compared to SNZZF. This indicates potentially higher risk in terms of short-term price fluctuations for ASAPF.Check SNZZF's competition here
ASAPF vs VMTHF Comparison July 2025
ASAPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASAPF stands at 19.5M. In comparison, VMTHF has a market cap of 110M. Regarding current trading prices, ASAPF is priced at $0.25, while VMTHF trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASAPF currently has a P/E ratio of -25.00, whereas VMTHF's P/E ratio is -1.09. In terms of profitability, ASAPF's ROE is -0.23%, compared to VMTHF's ROE of -0.23%. Regarding short-term risk, ASAPF is less volatile compared to VMTHF. This indicates potentially lower risk in terms of short-term price fluctuations for ASAPF.Check VMTHF's competition here
ASAPF vs JMDMF Comparison July 2025
ASAPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASAPF stands at 19.5M. In comparison, JMDMF has a market cap of 104.4M. Regarding current trading prices, ASAPF is priced at $0.25, while JMDMF trades at $3.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASAPF currently has a P/E ratio of -25.00, whereas JMDMF's P/E ratio is -27.83. In terms of profitability, ASAPF's ROE is -0.23%, compared to JMDMF's ROE of N/A. Regarding short-term risk, ASAPF is less volatile compared to JMDMF. This indicates potentially lower risk in terms of short-term price fluctuations for ASAPF.Check JMDMF's competition here
ASAPF vs IPDQF Comparison July 2025
ASAPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASAPF stands at 19.5M. In comparison, IPDQF has a market cap of 104.2M. Regarding current trading prices, ASAPF is priced at $0.25, while IPDQF trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASAPF currently has a P/E ratio of -25.00, whereas IPDQF's P/E ratio is -5.14. In terms of profitability, ASAPF's ROE is -0.23%, compared to IPDQF's ROE of -0.43%. Regarding short-term risk, ASAPF is less volatile compared to IPDQF. This indicates potentially lower risk in terms of short-term price fluctuations for ASAPF.Check IPDQF's competition here
ASAPF vs RSHUF Comparison July 2025
ASAPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASAPF stands at 19.5M. In comparison, RSHUF has a market cap of 91.5M. Regarding current trading prices, ASAPF is priced at $0.25, while RSHUF trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASAPF currently has a P/E ratio of -25.00, whereas RSHUF's P/E ratio is -5.81. In terms of profitability, ASAPF's ROE is -0.23%, compared to RSHUF's ROE of -2.32%. Regarding short-term risk, ASAPF is less volatile compared to RSHUF. This indicates potentially lower risk in terms of short-term price fluctuations for ASAPF.Check RSHUF's competition here
ASAPF vs SOMNF Comparison July 2025
ASAPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASAPF stands at 19.5M. In comparison, SOMNF has a market cap of 90.8M. Regarding current trading prices, ASAPF is priced at $0.25, while SOMNF trades at $0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASAPF currently has a P/E ratio of -25.00, whereas SOMNF's P/E ratio is -14.00. In terms of profitability, ASAPF's ROE is -0.23%, compared to SOMNF's ROE of -0.38%. Regarding short-term risk, ASAPF is more volatile compared to SOMNF. This indicates potentially higher risk in terms of short-term price fluctuations for ASAPF.Check SOMNF's competition here
ASAPF vs CKMTF Comparison July 2025
ASAPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASAPF stands at 19.5M. In comparison, CKMTF has a market cap of 85.2M. Regarding current trading prices, ASAPF is priced at $0.25, while CKMTF trades at $12.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASAPF currently has a P/E ratio of -25.00, whereas CKMTF's P/E ratio is -3.32. In terms of profitability, ASAPF's ROE is -0.23%, compared to CKMTF's ROE of +2.58%. Regarding short-term risk, ASAPF is more volatile compared to CKMTF. This indicates potentially higher risk in terms of short-term price fluctuations for ASAPF.Check CKMTF's competition here
ASAPF vs FDMDF Comparison July 2025
ASAPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASAPF stands at 19.5M. In comparison, FDMDF has a market cap of 75.7M. Regarding current trading prices, ASAPF is priced at $0.25, while FDMDF trades at $0.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASAPF currently has a P/E ratio of -25.00, whereas FDMDF's P/E ratio is -2.32. In terms of profitability, ASAPF's ROE is -0.23%, compared to FDMDF's ROE of -0.44%. Regarding short-term risk, ASAPF is less volatile compared to FDMDF. This indicates potentially lower risk in terms of short-term price fluctuations for ASAPF.Check FDMDF's competition here
ASAPF vs RDGL Comparison July 2025
ASAPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASAPF stands at 19.5M. In comparison, RDGL has a market cap of 60.6M. Regarding current trading prices, ASAPF is priced at $0.25, while RDGL trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASAPF currently has a P/E ratio of -25.00, whereas RDGL's P/E ratio is -13.36. In terms of profitability, ASAPF's ROE is -0.23%, compared to RDGL's ROE of -1.57%. Regarding short-term risk, ASAPF is less volatile compared to RDGL. This indicates potentially lower risk in terms of short-term price fluctuations for ASAPF.Check RDGL's competition here
ASAPF vs BLOZF Comparison July 2025
ASAPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASAPF stands at 19.5M. In comparison, BLOZF has a market cap of 50.8M. Regarding current trading prices, ASAPF is priced at $0.25, while BLOZF trades at $0.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASAPF currently has a P/E ratio of -25.00, whereas BLOZF's P/E ratio is -22.06. In terms of profitability, ASAPF's ROE is -0.23%, compared to BLOZF's ROE of -0.89%. Regarding short-term risk, ASAPF is less volatile compared to BLOZF. This indicates potentially lower risk in terms of short-term price fluctuations for ASAPF.Check BLOZF's competition here
ASAPF vs BRNHF Comparison July 2025
ASAPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASAPF stands at 19.5M. In comparison, BRNHF has a market cap of 42.2M. Regarding current trading prices, ASAPF is priced at $0.25, while BRNHF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASAPF currently has a P/E ratio of -25.00, whereas BRNHF's P/E ratio is -1.33. In terms of profitability, ASAPF's ROE is -0.23%, compared to BRNHF's ROE of -0.09%. Regarding short-term risk, ASAPF is more volatile compared to BRNHF. This indicates potentially higher risk in terms of short-term price fluctuations for ASAPF.Check BRNHF's competition here
ASAPF vs NVYTF Comparison July 2025
ASAPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASAPF stands at 19.5M. In comparison, NVYTF has a market cap of 38.9M. Regarding current trading prices, ASAPF is priced at $0.25, while NVYTF trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASAPF currently has a P/E ratio of -25.00, whereas NVYTF's P/E ratio is -0.74. In terms of profitability, ASAPF's ROE is -0.23%, compared to NVYTF's ROE of +0.00%. Regarding short-term risk, ASAPF is less volatile compared to NVYTF. This indicates potentially lower risk in terms of short-term price fluctuations for ASAPF.Check NVYTF's competition here
ASAPF vs TLTFF Comparison July 2025
ASAPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASAPF stands at 19.5M. In comparison, TLTFF has a market cap of 38.4M. Regarding current trading prices, ASAPF is priced at $0.25, while TLTFF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASAPF currently has a P/E ratio of -25.00, whereas TLTFF's P/E ratio is -15.30. In terms of profitability, ASAPF's ROE is -0.23%, compared to TLTFF's ROE of -2.57%. Regarding short-term risk, ASAPF is less volatile compared to TLTFF. This indicates potentially lower risk in terms of short-term price fluctuations for ASAPF.Check TLTFF's competition here
ASAPF vs ELXMF Comparison July 2025
ASAPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASAPF stands at 19.5M. In comparison, ELXMF has a market cap of 28.4M. Regarding current trading prices, ASAPF is priced at $0.25, while ELXMF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASAPF currently has a P/E ratio of -25.00, whereas ELXMF's P/E ratio is -2.00. In terms of profitability, ASAPF's ROE is -0.23%, compared to ELXMF's ROE of -0.46%. Regarding short-term risk, ASAPF is more volatile compared to ELXMF. This indicates potentially higher risk in terms of short-term price fluctuations for ASAPF.Check ELXMF's competition here
ASAPF vs MKEAF Comparison July 2025
ASAPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASAPF stands at 19.5M. In comparison, MKEAF has a market cap of 25.9M. Regarding current trading prices, ASAPF is priced at $0.25, while MKEAF trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASAPF currently has a P/E ratio of -25.00, whereas MKEAF's P/E ratio is -4.11. In terms of profitability, ASAPF's ROE is -0.23%, compared to MKEAF's ROE of +0.50%. Regarding short-term risk, ASAPF is more volatile compared to MKEAF. This indicates potentially higher risk in terms of short-term price fluctuations for ASAPF.Check MKEAF's competition here
ASAPF vs EMITF Comparison July 2025
ASAPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASAPF stands at 19.5M. In comparison, EMITF has a market cap of 24.6M. Regarding current trading prices, ASAPF is priced at $0.25, while EMITF trades at $1.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASAPF currently has a P/E ratio of -25.00, whereas EMITF's P/E ratio is -12.33. In terms of profitability, ASAPF's ROE is -0.23%, compared to EMITF's ROE of +0.05%. Regarding short-term risk, ASAPF is less volatile compared to EMITF. This indicates potentially lower risk in terms of short-term price fluctuations for ASAPF.Check EMITF's competition here
ASAPF vs KBBTF Comparison July 2025
ASAPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASAPF stands at 19.5M. In comparison, KBBTF has a market cap of 24.1M. Regarding current trading prices, ASAPF is priced at $0.25, while KBBTF trades at $0.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASAPF currently has a P/E ratio of -25.00, whereas KBBTF's P/E ratio is -2.30. In terms of profitability, ASAPF's ROE is -0.23%, compared to KBBTF's ROE of N/A. Regarding short-term risk, ASAPF is more volatile compared to KBBTF. This indicates potentially higher risk in terms of short-term price fluctuations for ASAPF.Check KBBTF's competition here
ASAPF vs POSC Comparison July 2025
ASAPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASAPF stands at 19.5M. In comparison, POSC has a market cap of 23.1M. Regarding current trading prices, ASAPF is priced at $0.25, while POSC trades at $1.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASAPF currently has a P/E ratio of -25.00, whereas POSC's P/E ratio is 0.40. In terms of profitability, ASAPF's ROE is -0.23%, compared to POSC's ROE of +9.25%. Regarding short-term risk, ASAPF is less volatile compared to POSC. This indicates potentially lower risk in terms of short-term price fluctuations for ASAPF.Check POSC's competition here
ASAPF vs GTHP Comparison July 2025
ASAPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASAPF stands at 19.5M. In comparison, GTHP has a market cap of 19.7M. Regarding current trading prices, ASAPF is priced at $0.25, while GTHP trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASAPF currently has a P/E ratio of -25.00, whereas GTHP's P/E ratio is -5.00. In terms of profitability, ASAPF's ROE is -0.23%, compared to GTHP's ROE of +0.78%. Regarding short-term risk, ASAPF is less volatile compared to GTHP. This indicates potentially lower risk in terms of short-term price fluctuations for ASAPF.Check GTHP's competition here
ASAPF vs MDXHF Comparison July 2025
ASAPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASAPF stands at 19.5M. In comparison, MDXHF has a market cap of 18.8M. Regarding current trading prices, ASAPF is priced at $0.25, while MDXHF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASAPF currently has a P/E ratio of -25.00, whereas MDXHF's P/E ratio is -0.08. In terms of profitability, ASAPF's ROE is -0.23%, compared to MDXHF's ROE of +0.49%. Regarding short-term risk, ASAPF is less volatile compared to MDXHF. This indicates potentially lower risk in terms of short-term price fluctuations for ASAPF.Check MDXHF's competition here
ASAPF vs PYNKF Comparison July 2025
ASAPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASAPF stands at 19.5M. In comparison, PYNKF has a market cap of 18.1M. Regarding current trading prices, ASAPF is priced at $0.25, while PYNKF trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASAPF currently has a P/E ratio of -25.00, whereas PYNKF's P/E ratio is -0.87. In terms of profitability, ASAPF's ROE is -0.23%, compared to PYNKF's ROE of -1.58%. Regarding short-term risk, ASAPF is less volatile compared to PYNKF. This indicates potentially lower risk in terms of short-term price fluctuations for ASAPF.Check PYNKF's competition here
ASAPF vs DIZTF Comparison July 2025
ASAPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASAPF stands at 19.5M. In comparison, DIZTF has a market cap of 18M. Regarding current trading prices, ASAPF is priced at $0.25, while DIZTF trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASAPF currently has a P/E ratio of -25.00, whereas DIZTF's P/E ratio is -11.16. In terms of profitability, ASAPF's ROE is -0.23%, compared to DIZTF's ROE of -2.22%. Regarding short-term risk, ASAPF is less volatile compared to DIZTF. This indicates potentially lower risk in terms of short-term price fluctuations for ASAPF.Check DIZTF's competition here
ASAPF vs VPTDF Comparison July 2025
ASAPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASAPF stands at 19.5M. In comparison, VPTDF has a market cap of 17.8M. Regarding current trading prices, ASAPF is priced at $0.25, while VPTDF trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASAPF currently has a P/E ratio of -25.00, whereas VPTDF's P/E ratio is -5.34. In terms of profitability, ASAPF's ROE is -0.23%, compared to VPTDF's ROE of +1.70%. Regarding short-term risk, ASAPF is less volatile compared to VPTDF. This indicates potentially lower risk in terms of short-term price fluctuations for ASAPF.Check VPTDF's competition here
ASAPF vs TMDIF Comparison July 2025
ASAPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASAPF stands at 19.5M. In comparison, TMDIF has a market cap of 13.9M. Regarding current trading prices, ASAPF is priced at $0.25, while TMDIF trades at $0.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASAPF currently has a P/E ratio of -25.00, whereas TMDIF's P/E ratio is -0.65. In terms of profitability, ASAPF's ROE is -0.23%, compared to TMDIF's ROE of -1.38%. Regarding short-term risk, ASAPF is less volatile compared to TMDIF. This indicates potentially lower risk in terms of short-term price fluctuations for ASAPF.Check TMDIF's competition here
ASAPF vs PLLWF Comparison July 2025
ASAPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASAPF stands at 19.5M. In comparison, PLLWF has a market cap of 13.3M. Regarding current trading prices, ASAPF is priced at $0.25, while PLLWF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASAPF currently has a P/E ratio of -25.00, whereas PLLWF's P/E ratio is -1.10. In terms of profitability, ASAPF's ROE is -0.23%, compared to PLLWF's ROE of -0.61%. Regarding short-term risk, ASAPF is less volatile compared to PLLWF. This indicates potentially lower risk in terms of short-term price fluctuations for ASAPF.Check PLLWF's competition here
ASAPF vs IMEXF Comparison July 2025
ASAPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASAPF stands at 19.5M. In comparison, IMEXF has a market cap of 11.9M. Regarding current trading prices, ASAPF is priced at $0.25, while IMEXF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASAPF currently has a P/E ratio of -25.00, whereas IMEXF's P/E ratio is N/A. In terms of profitability, ASAPF's ROE is -0.23%, compared to IMEXF's ROE of +0.20%. Regarding short-term risk, ASAPF is more volatile compared to IMEXF. This indicates potentially higher risk in terms of short-term price fluctuations for ASAPF.Check IMEXF's competition here
ASAPF vs ATBPF Comparison July 2025
ASAPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASAPF stands at 19.5M. In comparison, ATBPF has a market cap of 11.4M. Regarding current trading prices, ASAPF is priced at $0.25, while ATBPF trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASAPF currently has a P/E ratio of -25.00, whereas ATBPF's P/E ratio is -0.86. In terms of profitability, ASAPF's ROE is -0.23%, compared to ATBPF's ROE of -0.40%. Regarding short-term risk, ASAPF is less volatile compared to ATBPF. This indicates potentially lower risk in terms of short-term price fluctuations for ASAPF.Check ATBPF's competition here
ASAPF vs LXXGF Comparison July 2025
ASAPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASAPF stands at 19.5M. In comparison, LXXGF has a market cap of 11.3M. Regarding current trading prices, ASAPF is priced at $0.25, while LXXGF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASAPF currently has a P/E ratio of -25.00, whereas LXXGF's P/E ratio is -0.85. In terms of profitability, ASAPF's ROE is -0.23%, compared to LXXGF's ROE of -1.23%. Regarding short-term risk, ASAPF is more volatile compared to LXXGF. This indicates potentially higher risk in terms of short-term price fluctuations for ASAPF.Check LXXGF's competition here
ASAPF vs RMSL Comparison July 2025
ASAPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASAPF stands at 19.5M. In comparison, RMSL has a market cap of 10.4M. Regarding current trading prices, ASAPF is priced at $0.25, while RMSL trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASAPF currently has a P/E ratio of -25.00, whereas RMSL's P/E ratio is 0.68. In terms of profitability, ASAPF's ROE is -0.23%, compared to RMSL's ROE of -2.03%. Regarding short-term risk, ASAPF is less volatile compared to RMSL. This indicates potentially lower risk in terms of short-term price fluctuations for ASAPF.Check RMSL's competition here
ASAPF vs NGMDF Comparison July 2025
ASAPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASAPF stands at 19.5M. In comparison, NGMDF has a market cap of 8.5M. Regarding current trading prices, ASAPF is priced at $0.25, while NGMDF trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASAPF currently has a P/E ratio of -25.00, whereas NGMDF's P/E ratio is -3.74. In terms of profitability, ASAPF's ROE is -0.23%, compared to NGMDF's ROE of +0.36%. Regarding short-term risk, ASAPF is more volatile compared to NGMDF. This indicates potentially higher risk in terms of short-term price fluctuations for ASAPF.Check NGMDF's competition here
ASAPF vs FZMD Comparison July 2025
ASAPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASAPF stands at 19.5M. In comparison, FZMD has a market cap of 7.4M. Regarding current trading prices, ASAPF is priced at $0.25, while FZMD trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASAPF currently has a P/E ratio of -25.00, whereas FZMD's P/E ratio is 2.00. In terms of profitability, ASAPF's ROE is -0.23%, compared to FZMD's ROE of +0.13%. Regarding short-term risk, ASAPF is more volatile compared to FZMD. This indicates potentially higher risk in terms of short-term price fluctuations for ASAPF.Check FZMD's competition here
ASAPF vs ALRTF Comparison July 2025
ASAPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASAPF stands at 19.5M. In comparison, ALRTF has a market cap of 6.4M. Regarding current trading prices, ASAPF is priced at $0.25, while ALRTF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASAPF currently has a P/E ratio of -25.00, whereas ALRTF's P/E ratio is -0.33. In terms of profitability, ASAPF's ROE is -0.23%, compared to ALRTF's ROE of +0.52%. Regarding short-term risk, ASAPF is more volatile compared to ALRTF. This indicates potentially higher risk in terms of short-term price fluctuations for ASAPF.Check ALRTF's competition here
ASAPF vs QLIS Comparison July 2025
ASAPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASAPF stands at 19.5M. In comparison, QLIS has a market cap of 5.5M. Regarding current trading prices, ASAPF is priced at $0.25, while QLIS trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASAPF currently has a P/E ratio of -25.00, whereas QLIS's P/E ratio is 2.22. In terms of profitability, ASAPF's ROE is -0.23%, compared to QLIS's ROE of -1.41%. Regarding short-term risk, ASAPF is more volatile compared to QLIS. This indicates potentially higher risk in terms of short-term price fluctuations for ASAPF.Check QLIS's competition here
ASAPF vs RHNMF Comparison July 2025
ASAPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASAPF stands at 19.5M. In comparison, RHNMF has a market cap of 5.4M. Regarding current trading prices, ASAPF is priced at $0.25, while RHNMF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASAPF currently has a P/E ratio of -25.00, whereas RHNMF's P/E ratio is -0.95. In terms of profitability, ASAPF's ROE is -0.23%, compared to RHNMF's ROE of +15.91%. Regarding short-term risk, ASAPF is less volatile compared to RHNMF. This indicates potentially lower risk in terms of short-term price fluctuations for ASAPF.Check RHNMF's competition here
ASAPF vs VYCO Comparison July 2025
ASAPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASAPF stands at 19.5M. In comparison, VYCO has a market cap of 4.3M. Regarding current trading prices, ASAPF is priced at $0.25, while VYCO trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASAPF currently has a P/E ratio of -25.00, whereas VYCO's P/E ratio is -13.00. In terms of profitability, ASAPF's ROE is -0.23%, compared to VYCO's ROE of +0.03%. Regarding short-term risk, ASAPF is more volatile compared to VYCO. This indicates potentially higher risk in terms of short-term price fluctuations for ASAPF.Check VYCO's competition here
ASAPF vs NUMD Comparison July 2025
ASAPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASAPF stands at 19.5M. In comparison, NUMD has a market cap of 4.2M. Regarding current trading prices, ASAPF is priced at $0.25, while NUMD trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASAPF currently has a P/E ratio of -25.00, whereas NUMD's P/E ratio is 5.00. In terms of profitability, ASAPF's ROE is -0.23%, compared to NUMD's ROE of +0.35%. Regarding short-term risk, ASAPF is less volatile compared to NUMD. This indicates potentially lower risk in terms of short-term price fluctuations for ASAPF.Check NUMD's competition here
ASAPF vs LBLTF Comparison July 2025
ASAPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASAPF stands at 19.5M. In comparison, LBLTF has a market cap of 4.1M. Regarding current trading prices, ASAPF is priced at $0.25, while LBLTF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASAPF currently has a P/E ratio of -25.00, whereas LBLTF's P/E ratio is -0.01. In terms of profitability, ASAPF's ROE is -0.23%, compared to LBLTF's ROE of +0.00%. Regarding short-term risk, ASAPF is more volatile compared to LBLTF. This indicates potentially higher risk in terms of short-term price fluctuations for ASAPF.Check LBLTF's competition here
ASAPF vs ADMT Comparison July 2025
ASAPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASAPF stands at 19.5M. In comparison, ADMT has a market cap of 4M. Regarding current trading prices, ASAPF is priced at $0.25, while ADMT trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASAPF currently has a P/E ratio of -25.00, whereas ADMT's P/E ratio is -5.87. In terms of profitability, ASAPF's ROE is -0.23%, compared to ADMT's ROE of -0.63%. Regarding short-term risk, ASAPF is more volatile compared to ADMT. This indicates potentially higher risk in terms of short-term price fluctuations for ASAPF.Check ADMT's competition here
ASAPF vs BIEL Comparison July 2025
ASAPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASAPF stands at 19.5M. In comparison, BIEL has a market cap of 3.6M. Regarding current trading prices, ASAPF is priced at $0.25, while BIEL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASAPF currently has a P/E ratio of -25.00, whereas BIEL's P/E ratio is N/A. In terms of profitability, ASAPF's ROE is -0.23%, compared to BIEL's ROE of +0.04%. Regarding short-term risk, ASAPF is less volatile compared to BIEL. This indicates potentially lower risk in terms of short-term price fluctuations for ASAPF.Check BIEL's competition here
ASAPF vs VANIW Comparison July 2025
ASAPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASAPF stands at 19.5M. In comparison, VANIW has a market cap of 3.4M. Regarding current trading prices, ASAPF is priced at $0.25, while VANIW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASAPF currently has a P/E ratio of -25.00, whereas VANIW's P/E ratio is N/A. In terms of profitability, ASAPF's ROE is -0.23%, compared to VANIW's ROE of -1.33%. Regarding short-term risk, ASAPF is less volatile compared to VANIW. This indicates potentially lower risk in terms of short-term price fluctuations for ASAPF.Check VANIW's competition here
ASAPF vs PMEDF Comparison July 2025
ASAPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASAPF stands at 19.5M. In comparison, PMEDF has a market cap of 3.3M. Regarding current trading prices, ASAPF is priced at $0.25, while PMEDF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASAPF currently has a P/E ratio of -25.00, whereas PMEDF's P/E ratio is -1.69. In terms of profitability, ASAPF's ROE is -0.23%, compared to PMEDF's ROE of +1.68%. Regarding short-term risk, ASAPF is less volatile compared to PMEDF. This indicates potentially lower risk in terms of short-term price fluctuations for ASAPF.Check PMEDF's competition here
ASAPF vs TBRIF Comparison July 2025
ASAPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASAPF stands at 19.5M. In comparison, TBRIF has a market cap of 3.2M. Regarding current trading prices, ASAPF is priced at $0.25, while TBRIF trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASAPF currently has a P/E ratio of -25.00, whereas TBRIF's P/E ratio is -0.84. In terms of profitability, ASAPF's ROE is -0.23%, compared to TBRIF's ROE of -2.28%. Regarding short-term risk, ASAPF is more volatile compared to TBRIF. This indicates potentially higher risk in terms of short-term price fluctuations for ASAPF.Check TBRIF's competition here
ASAPF vs ESMC Comparison July 2025
ASAPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASAPF stands at 19.5M. In comparison, ESMC has a market cap of 3M. Regarding current trading prices, ASAPF is priced at $0.25, while ESMC trades at $0.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASAPF currently has a P/E ratio of -25.00, whereas ESMC's P/E ratio is 8.00. In terms of profitability, ASAPF's ROE is -0.23%, compared to ESMC's ROE of +0.00%. Regarding short-term risk, ASAPF is more volatile compared to ESMC. This indicates potentially higher risk in terms of short-term price fluctuations for ASAPF.Check ESMC's competition here
ASAPF vs ODYY Comparison July 2025
ASAPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASAPF stands at 19.5M. In comparison, ODYY has a market cap of 2.3M. Regarding current trading prices, ASAPF is priced at $0.25, while ODYY trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASAPF currently has a P/E ratio of -25.00, whereas ODYY's P/E ratio is -0.16. In terms of profitability, ASAPF's ROE is -0.23%, compared to ODYY's ROE of +2.30%. Regarding short-term risk, ASAPF is less volatile compared to ODYY. This indicates potentially lower risk in terms of short-term price fluctuations for ASAPF.Check ODYY's competition here
ASAPF vs USAQ Comparison July 2025
ASAPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASAPF stands at 19.5M. In comparison, USAQ has a market cap of 2.3M. Regarding current trading prices, ASAPF is priced at $0.25, while USAQ trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASAPF currently has a P/E ratio of -25.00, whereas USAQ's P/E ratio is -5.00. In terms of profitability, ASAPF's ROE is -0.23%, compared to USAQ's ROE of +0.67%. Regarding short-term risk, ASAPF is less volatile compared to USAQ. This indicates potentially lower risk in terms of short-term price fluctuations for ASAPF.Check USAQ's competition here
ASAPF vs CRRVF Comparison July 2025
ASAPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASAPF stands at 19.5M. In comparison, CRRVF has a market cap of 1.5M. Regarding current trading prices, ASAPF is priced at $0.25, while CRRVF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASAPF currently has a P/E ratio of -25.00, whereas CRRVF's P/E ratio is N/A. In terms of profitability, ASAPF's ROE is -0.23%, compared to CRRVF's ROE of +0.00%. Regarding short-term risk, ASAPF is less volatile compared to CRRVF. This indicates potentially lower risk in terms of short-term price fluctuations for ASAPF.Check CRRVF's competition here
ASAPF vs LLBO Comparison July 2025
ASAPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASAPF stands at 19.5M. In comparison, LLBO has a market cap of 1.3M. Regarding current trading prices, ASAPF is priced at $0.25, while LLBO trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASAPF currently has a P/E ratio of -25.00, whereas LLBO's P/E ratio is N/A. In terms of profitability, ASAPF's ROE is -0.23%, compared to LLBO's ROE of +0.00%. Regarding short-term risk, ASAPF is less volatile compared to LLBO. This indicates potentially lower risk in terms of short-term price fluctuations for ASAPF.Check LLBO's competition here
ASAPF vs CYDX Comparison July 2025
ASAPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASAPF stands at 19.5M. In comparison, CYDX has a market cap of 1.3M. Regarding current trading prices, ASAPF is priced at $0.25, while CYDX trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASAPF currently has a P/E ratio of -25.00, whereas CYDX's P/E ratio is 0.33. In terms of profitability, ASAPF's ROE is -0.23%, compared to CYDX's ROE of +0.17%. Regarding short-term risk, ASAPF is more volatile compared to CYDX. This indicates potentially higher risk in terms of short-term price fluctuations for ASAPF.Check CYDX's competition here